These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23143368)

  • 1. Current approach to latent tuberculosis diagnosis and treatment among medical center occupational health physicians.
    Vinnard C; Linkin D; Behrman A
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1262-5. PubMed ID: 23143368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and Treatment of Latent Tuberculosis Among Patients Receiving Biologic Agents: A National and International Survey of Rheumatologists.
    Tran NQ; Garcia-Rosell M; Pattanaik D; Raza SH; Carbone L
    J Clin Rheumatol; 2017 Jan; 23(1):6-11. PubMed ID: 28002150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of latent tuberculosis infection among healthcare workers in China as detected by two interferon-gamma release assays.
    Wei Z; Yang M; Quan B; Wang Y; Wu Y; Ji B
    J Hosp Infect; 2013 Aug; 84(4):323-5. PubMed ID: 23806839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF-alpha treatment--the tuberculin skin test is useful.
    Goujon C; Nosbaum A; Bensaid B; Rozières A; Nicolas JF; Bérard F
    Eur J Dermatol; 2012; 22(5):701-2. PubMed ID: 23032063
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
    Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
    Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deployment-related testing and treatment for latent tuberculosis infection, part II.
    Mancuso JD; Keep LW
    Mil Med; 2011 Oct; 176(10):1088-92. PubMed ID: 22128639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can ELISpot replace the tuberculin skin test for latent tuberculosis?
    Greveson K
    Br J Nurs; 2009 Nov 12-25; 18(20):1248-54. PubMed ID: 20081663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of an interferon-gamma release assay to diagnose latent tuberculosis infection during pregnancy.
    Lighter-Fisher J; Surette AM
    Obstet Gynecol; 2012 Jun; 119(6):1088-95. PubMed ID: 22569120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the diagnosis of latent tuberculosis infection.
    Schluger NW
    Semin Respir Crit Care Med; 2013 Feb; 34(1):60-6. PubMed ID: 23460006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on latent tuberculosis infection.
    Hartman-Adams H; Clark K; Juckett G
    Am Fam Physician; 2014 Jun; 89(11):889-96. PubMed ID: 25077395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of interferon-γ release assay on the latent tuberculosis cascade of care: a population-based study.
    Roth DZ; Ronald LA; Ling D; Chiang LY; Cook VJ; Morshed MG; Johnston JC
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331032
    [No Abstract]   [Full Text] [Related]  

  • 14. Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting.
    Kardos M; Kimball AB
    J Am Acad Dermatol; 2012 Jan; 66(1):148-52. PubMed ID: 22177633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the use of a negative interferon-γ release assay for tuberculosis screening before TNF antagonist therapy.
    Woodfield G; Passey-Heaton B; Chakrabarti A; Pozniak A; Loebinger MR
    Eur Respir J; 2014 Nov; 44(5):1369-72. PubMed ID: 25186258
    [No Abstract]   [Full Text] [Related]  

  • 16. Serial screening for latent tuberculosis infection in healthcare workers in low-risk settings.
    Zellweger JP; Rieder HL
    Am J Respir Crit Care Med; 2014 Jan; 189(1):3-4. PubMed ID: 24381985
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interferon-Gamma Release Assays in the diagnosis of latent tuberculosis infection in clinical situations].
    Borkowska D; Radzikowska E; Załęska J; Ziołkowski J; Klatt M; Zwolska Z; Augustynowicz-Kopeć E; Roszkowski-Śliż K
    Pneumonol Alergol Pol; 2014; 82(1):39-45. PubMed ID: 24391070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, experiences, and attitudes toward Mantoux test among medical and health professional students in Italy: a cross-sectional study.
    Montagna MT; Mascipinto S; Pousis C; Bianchi FP; Caggiano G; Carpagnano LF; De Giglio O; Barbuti G; Auxilia F; Destrebecq A; Castaldi S; Baldovin T; Bargellini A; Righi E; Boccia G; Santoro E; Casini B; Baggiani A; Novati R; Oriani R; Odone A; Mezzoiuso AG; Orsi GB; Napoli C; Pasquarella C; Veronesi L; Ripabelli G; Sammarco ML; Rossini A; Squeri R; Laganà P; Antonuccio GM; Genovese C; Tardivo S; Torre I; Alfano R; Pennino F; Torregrossa MV; Barchitta M; Agodi A
    Ann Ig; 2018; 30(5 Supple 2):86-98. PubMed ID: 30374514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of latent tuberculosis in individuals with recent exposure: tuberculin skin test versus interferon-gamma release assay.
    Shokrollahi MR; Noorbaksh S; Nasehi L; Movahedi Z
    Br J Biomed Sci; 2014; 71(3):125-6. PubMed ID: 25265758
    [No Abstract]   [Full Text] [Related]  

  • 20. Occupational screening of health care workers for tuberculosis infection: tuberculin skin testing or interferon-γ release assays?
    Pai M; Banaei N
    Occup Med (Lond); 2013 Oct; 63(7):458-60. PubMed ID: 24097956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.